Plasma metabolomics profile alterations in the onset and progression of paediatric immune thrombocytopenia
British Journal of Haematology · 2026
DOI: 10.1111/bjh.70657 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2026. Verfasst von Tong Zou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cell and Gene Therapy Laboratory, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for …. Hauptthemen laut MEDLINE: Purpura, Thrombocytopenic, Idiopathic, Metabolomics, Metabolome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Beijing Natural Science Foundation, Natural Science Foundation of Beijing Municipality.
Abstract (Originalsprache)
Immune thrombocytopenia (ITP) is an autoimmune disorder, characterized by immune‐mediated platelet destruction and decreased platelet production. To investigate metabolic alterations associated with paediatric ITP and disease chronicity, we performed untargeted plasma metabolomics analysis in 60 newly diagnosed ITP (nITP) patients, 39 chronic ITP (cITP) patients and 39 healthy controls (HC) from Beijing Children's Hospital between October 2020 and August 2024. A total of 30 differential metabolites were identified between ITP patients and HC, with altered tryptophan metabolism among the most significantly enriched metabolic pathways. Random forest analysis achieved an accuracy of 83.9% and a precision of 95.1%. Glycocholic acid demonstrated strong discriminatory performance, with an area under the receiver operating characteristic curve of 0.882 (95% confidence interval: 0.814–0.950). In addition, phosphatidylcholine‐related metabolites and sphingolipid‐related metabolites were associated with metabolic alterations observed between nITP and cITP. Overall, paediatric ITP was associated with distinct plasma metabolic alterations, particularly involving tryptophan metabolism, bile acid metabolism and lipid metabolism. These findings provide additional insights into metabolic alterations associated with paediatric ITP and disease chronicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cell and Gene Therapy Laboratory, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
- Clinical Research Center, Department of Pharmacy, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
- Hematology Department, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
- Beijing Key Laboratory of Pediatric Hematology Oncology; Ministry of Education Key Laboratory of Major Diseases in Children, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health…
ORCID-Profile: Tong Zou, Yuncui Yu, Jingyao Ma, Tianyou Wang
Förderung
- National Natural Science Foundation of China
- Beijing Natural Science Foundation
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Zou, T., Ouyang, J., Lin, Z., Yu, Y., Hu, Y., Ma, J., Chen, H., Wang, T., Wu, R., & Chen, Z. (2026). Plasma metabolomics profile alterations in the onset and progression of paediatric immune thrombocytopenia. British Journal of Haematology. https://doi.org/10.1111/bjh.70657
Vancouver
Zou T, Ouyang J, Lin Z, Yu Y, Hu Y, Ma J, et al. Plasma metabolomics profile alterations in the onset and progression of paediatric immune thrombocytopenia. British Journal of Haematology. 2026. doi:10.1111/bjh.70657
BibTeX
@article{Zou2026,
author = {Zou, Tong and Ouyang, Juntao and Lin, Zheyan and Yu, Yuncui and Hu, Yu and Ma, Jingyao and Chen, Hui and Wang, Tianyou and Wu, Runhui and Chen, Zhenping},
title = {Plasma metabolomics profile alterations in the onset and progression of paediatric immune thrombocytopenia},
journal = {British Journal of Haematology},
year = {2026},
doi = {10.1111/bjh.70657}
}
EUVIMED